Job Overview
Job description
- Salary:
- USD 150 - 235 per hour
- Location:
- United States
- Work arrangement:
- Remote
Role Summary
Mercor connects elite creative and technical talent with leading AI research labs. Headquartered in San Francisco, our investors include Benchmark , General Catalyst , Peter Thiel , Adam D'Angelo , Larry Summers , and Jack Dorsey .
- Position: Disease-Area Clinician — Trial Endpoints & Prescribing
- Type: Contract
- Compensation: $150–$235/hour
- Location: Remote
- Duration: 1–2 week pilot
- Role Responsibilities
Create and critique rubrics that analyze commercial drugs and drug-development programs.
Interpret clinical trial endpoints and judge whether results would change prescribing.
Assess implications for real-world uptake in your therapeutic area.
Apply expertise across the pilot's set of drugs and programs.
Work independently and asynchronously to meet deadlines while improving AI evaluation processes.
Requirements
- US-based disease-area clinician (practising physician, MD/DO ).
- Familiarity with biotech/pharma development programs.
- Deep expertise in a specific therapeutic area.
- Board-certified and actively practising in your specialty.
- Compensation & Legal
- Hourly contractor
- Application Process (Takes 20–30 mins to complete)
- Upload resume
- AI interview based on your resume
- Submit form
- Resources & Support
- For details about the interview process and platform information, please check:
Additional Information
PS: Our team reviews applications daily. Please complete your AI interview and application steps to be considered for this opportunity.
- Role:
- Therapeutic Clinician - Fully Remote | Upto $235/hr Part-time
- Job Type:
- Contractor
Company profile
mercor
mercor.comMercor is an AI data company that connects domain experts across hundreds of professional fields with frontier AI labs and enterprises. Experts on its platform train and evaluate AI models, and its APEX benchmark family measures how AI performs on real-world professional work. Mercor Enterprise helps large companies capture how their most skilled people work and turn that expertise into AI agents. Founded in 2023, the company has offices in San Francisco, NYC and London.
- Founded
- 2023
- Funding Stage
- Series C